Figure 5.
Figure 5. CD150 and SH2D1A expression in reactive tonsils and primary lymphoma cells. Immunohistochemical staining of CD150 (left panels: A, C, E, G) and SH2D1A (right panels: B, D, F, H,) on reactive tonsils (A, B), lymph node sections from patients with GC-DLBCL (C, D), ABC-DLBCL (E, F), and HD (G, H). CD150 and SH2D1A were coexpressed in malignant cells in ABC-DLBCL and HD. Original magnifications: 100 × (A, B, H), 400 × (C-F, and insets in A and B), 1000 × (G and H inset). H inset was magnified with Photoshop software (Adobe Systems, San Jose, CA). DAB staining shows specific reactions in brown.

CD150 and SH2D1A expression in reactive tonsils and primary lymphoma cells. Immunohistochemical staining of CD150 (left panels: A, C, E, G) and SH2D1A (right panels: B, D, F, H,) on reactive tonsils (A, B), lymph node sections from patients with GC-DLBCL (C, D), ABC-DLBCL (E, F), and HD (G, H). CD150 and SH2D1A were coexpressed in malignant cells in ABC-DLBCL and HD. Original magnifications: 100 × (A, B, H), 400 × (C-F, and insets in A and B), 1000 × (G and H inset). H inset was magnified with Photoshop software (Adobe Systems, San Jose, CA). DAB staining shows specific reactions in brown.

Close Modal

or Create an Account

Close Modal
Close Modal